News94h
New non-opioid drug offers hope for pain management
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
Psychology Today23h
"Medical" Marijuana and Chronic Pain
Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...
The Chemical Engineer3h
FDA approves ‘first’ of new class of non-addictive drugs for severe pain
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
STAT4h
Lilly expands GLP-1 research to hypertension, neuro conditions
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Vision Marine Technologies Files Patent Application for Distributed Control System Architecture in Electric Marine Vessels
MONTREAL, QC / ACCESS Newswire / 6, 2025 / Vision Marine Technologies Inc. (the "Company," "Vision Marine," "we," "us," "our") (Nasdaq:VMAR) is pleased to announce the filing of its latest patent ...